Field Trip Health Ltd. to Participate in Upcoming Conferences in November 2021
03 November 2021 - 10:30PM
Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field
Trip"), a global leader in the development and delivery of
psychedelic therapies, announced today that during the month of
November management will attend the Microdose Wonderland: Miami
Conference and present at the Stifel 2021 Virtual Healthcare
Conference and the Jefferies London Healthcare Conference.
Wonderland: Miami Conference
Field Trip’s Co-founder and Executive Chairman, Ronan Levy will
attend the Microdose Wonderland: Miami conference taking place
between November 8-9, 2021 to be held at the Adrienne Arsht Center
for the Performing Arts in Miami, FL.
Stifel 2021 Virtual Healthcare
ConferenceField Trip’s Co-founder and Executive Chairman,
Ronan Levy, and Field Trip’s Chief Scientific Officer, Dr. Nathan
Bryson, will present live at the Stifel Virtual Healthcare
Conference at 8:00am ET on Wednesday, November 17, 2021. The
presentation will be webcast and available through this link:
https://wsw.com/webcast/stifel58/ftrp/2118960.
Jefferies London Healthcare
ConferenceField Trip’s management team will present
virtually at the Jefferies London Healthcare Conference, taking
place on November 18-19. The webcast will be available to
registered attendees on-demand, beginning on Thursday, November 18,
2021 at 3:00am ET through Friday, November 19, 2021 at 12:00pm ET.
To view the webcast, please visit this link:
https://wsw.meetmax.com/admin/presenterlinks/?&group=TbkBHEif.
Field Trip’s management team will be available
for one-on-one meetings throughout the duration of the conferences.
To schedule a meeting with Field Trip’s management team, please
contact KCSA Strategic Communications at fieldtripIR@kcsa.com.
About Field Trip Health Ltd.
Field Trip is a global leader in the development
and delivery of psychedelic therapies. With our Field Trip
Discovery division leading the development of the next generation
of psychedelic molecules and conducting advanced research on
plant-based psychedelics and our Field Trip Health division
building centers for psychedelic therapies opening across North
America and Europe along with the digital and technological tools
that will enable massive scale, we help people in need with a
simple, evidence-based way to heal and heighten engagement with the
world.
Learn more at https://www.meetfieldtrip.com,
https://www.fieldtriphealth.com and
https://www.fieldtriphealth.nl.
Follow us on Twitter and Instagram:
@fieldtriphealth.
To receive company updates about Field Trip and
to be added to the email distribution list please sign up here.
Cautionary Note Regarding
Forward-Looking Information
This release includes forward-looking
information (within the meaning of Canadian securities laws and
within the meaning of the United States Private Securities
Litigation Reform Act of 1995) regarding Field Trip and its
business. Often but not always, forward-looking information can be
identified by the use of words such as "expect", "intends",
"anticipated", "believes" or variations (including negative
variations) of such words and phrases, or state that certain
actions, events or results "may", "could", "would" or "will" be
taken, occur or be achieved. Such statements are based on the
current expectations and views of future events of the management
of Field Trip and are based on assumptions and subject to risks and
uncertainties. Although the management of Field Trip believes that
the assumptions underlying these statements are reasonable, they
may prove to be incorrect. The forward-looking events and
circumstances discussed in this release may not occur and could
differ materially as a result of known and unknown risk factors and
uncertainties affecting the companies. Although Field Trip has
attempted to identify important factors that could cause actual
actions, events or results to differ materially from those
described in forward-looking statements, there may be other factors
that cause actions, events or results to differ from those
anticipated, estimated or intended. Accordingly, readers should not
place undue reliance on any forward-looking statements or
information. No forward-looking statement can be guaranteed. Except
as required by applicable securities laws, forward-looking
statements speak only as of the date on which they are made and
Field Trip does not undertake any obligation to publicly update or
revise any forward-looking statement, whether as a result of new
information, future events, or otherwise. Additional information
relating to Field Trip, including its Annual Information Form, can
be located on the SEDAR website at www.sedar.com and on the EDGAR
section of the SEC’s website at www.sec.gov.
This press release does not constitute an offer
to sell or the solicitation of an offer to buy securities.
Neither the Toronto Stock Exchange, nor its
Regulation Services Provider, have approved the contents of this
release or accept responsibility for the adequacy or accuracy of
this release.
CONTACTS:Media contacts:Rachel
MoskowitzAutumn
Communications202-276-7881press@fieldtriphealth.com
Nick Opich / McKenna MillerKCSA Strategic
Communications212-896-1206 /
347-487-6197press@fieldtriphealth.com
Investor contacts:Kathleen Heaney / Tim
ReganKCSA Strategic CommunicationsfieldtripIR@kcsa.com
SOURCE Field Trip Health Ltd.
Field Trip Health (TSX:FTRP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Field Trip Health (TSX:FTRP)
Historical Stock Chart
From Jul 2023 to Jul 2024